Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

After two years of treatment, natalizumab (NTZ) reduces the frequency of relapses and slows the progression of disability in relapsing‐remitting multiple sclerosis (RRMS) when compared with placebo ...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the immune system mistakenly attacks the myelin sheath, the protective ...

We’ve moved to Live Updates for coverage of this developing story. Follow the latest here. Multiple victims have been injured in a shooting at the Church of Jesus Christ of Latter-day Saints in Grand ...

She was diagnosed with multiple sclerosis in 2018. Selma Blair, 53, is giving fans an update on her battle with the autoimmune disease. Speaking on “Today” on NBC, the “Cruel Intentions” actress from ...

The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the optic nerve as a fifth anatomical location and allowing specific magnetic ...

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive ...

Researchers have identified a new subtype of multiple sclerosis that affects thinking and memory rather than mobility — and as many as 26 percent of people with MS may have it. Researchers have ...

As hackers exploit a high-severity vulnerability in SAP’s flagship Enterprise Resource Planning software product, the software maker is warning users of more than two dozen newly detected ...

Paul J. Becker does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...